Glial Fibrillary Acidic Protein in Tumours of the Nervous System
Overview
Affiliations
Glial fibrillary acidic protein (GFA) was assayed in nerve-tumour extracts and located in these tumours by indirect immunofluorescence study. We conclude that GFA is a specific marker of both malignant and normal astrocytes. Non-astrocytic tumours (oligodendroglioma, meningioma) do not contain GFA. Tumours with astrocytic differentiation potential (medulloblastoma) may contain GFA. Comparison of microscopic and GFA assays leads us to conclude that GFA concentration is proportional to the amount of malignant astrocytes in the tumour and inversely proportional to the necrotic area of a tumour. Normal tissue GFA and glioblastoma GFA were found to be immunologically identical.
Importance of GFAP isoform-specific analyses in astrocytoma.
van Bodegraven E, van Asperen J, Robe P, Hol E Glia. 2019; 67(8):1417-1433.
PMID: 30667110 PMC: 6617972. DOI: 10.1002/glia.23594.
Romijn H, Janszen A, Van den Bogert C Acta Neuropathol. 1994; 87(6):612-27.
PMID: 7522389 DOI: 10.1007/BF00293323.
Glial fibrillary acidic protein in medulloblastoma.
Mannoji H, Takeshita I, Fukui M, Ohta M, Kitamura K Acta Neuropathol. 1981; 55(1):63-9.
PMID: 7348008 DOI: 10.1007/BF00691533.
Immunobiologic aspects of the brain and human gliomas. A review.
Wikstrand C, Bigner D Am J Pathol. 1980; 98(2):517-68.
PMID: 6986786 PMC: 1903417.
Immunofluorescent staining of frozen sections for glial fibrillary acidic protein.
McKeever P, Laverson S, KORNBLITH P, Howard R, Quindlen E, Smith B Acta Neuropathol. 1982; 58(1):69-72.
PMID: 6753449 DOI: 10.1007/BF00692700.